MICONAL*DERM CREAM 30G 2%

MICONAL
2% dermatological cream
2% dermatological powder
2% vaginal cream
50 mg vaginal ovules
1200 mg vaginal capsules
0.2% vaginal wash

What it is and what it is used for
2% dermatological cream and 2% dermatological powder
Local treatment of skin and nail infections caused by dermatophytes or Candida.
2% vaginal cream, 50 mg vaginal ovules, 1200 mg vaginal capsules, 0.2% vaginal wash
Treatment of vaginal or vulvo-vaginal fungal infections, particularly those caused by Candida.

What you need to know before taking the medicine
Confirmed individual hypersensitivity to the product or to other chemically related compounds.

Warnings and precautions
Talk to your doctor or pharmacist before using Miconal.
If sensitization or irritation occurs, especially with prolonged use, discontinue treatment and contact your doctor.
Wash hands thoroughly after each application, unless the treatment involves the hands themselves.
It is advisable to apply the following hygiene measures to avoid sources of infection or re-infection (new infections by the same fungus):
• keep towels and underwear for personal use to avoid infecting other people;
• change underwear regularly to avoid re-infection.
Your sexual partner may also need treatment if infected. If in doubt, consult your doctor.
If sensitization or an allergic reaction occurs, treatment must be discontinued.

Prolonged use of the drug may lead to sensitization phenomena.
In such cases, it is necessary to interrupt the treatment and initiate appropriate therapy.
Miconal dermatological or vaginal cream contains benzoic acid
Benzoic acid can be mildly irritating to the skin, eyes, and mucous membranes.
Miconal dermatological or vaginal cream contains butylated hydroxyanisole
Butylated hydroxyanisole can cause local skin reactions (e.g., contact dermatitis) or irritation of the eyes and mucous membranes.
Miconal vaginal wash contains propylene glycol
Propylene glycol may cause skin irritation.

Possible side effects
Side effects with unknown frequency (frequency cannot be estimated from available data):
• Allergy, including severe allergic reaction that appears rapidly (anaphylactic and anaphylactoid reaction)
• Swelling of the face, mouth, lips and/or tongue (angioedema)
• Itching
• Skin rash (urticaria; rash)
• Contact dermatitis (skin inflammation)
• Erythema
• Burning sensation on the skin
• Reactions at the application site
• Vaginal irritation and burning (vaginal formulations)
• Pelvic cramps (vaginal formulations)
• Headache (vaginal formulations)

Reporting of side effects
If you get any side effects, including those not listed in this leaflet, talk to your doctor or pharmacist. You can also report side effects directly via the national reporting system at: https://www.aifa.gov.it/content/segnalazionireazioni-avverse.
By reporting side effects you can help provide more information on the safety of this medicine.